Nkgen Biotech Inc. · OTC:NKGN

Meteora Capital, LLC reported a 6.13% stake in Nkgen Biotech Inc. (Schedule 13G/A)

Event Mar 31, 2025 · Filed May 15, 2025

Meteora Capital, LLC reported a 6.13% stake in Nkgen Biotech Inc., 2,755,935 shares, as a passive investor on Mar 31, 2025. Filed May 15, 2025 (Schedule 13G/A).

Stake
6.13%
Shares
2,755,935
Intent
Passive
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
Meteora Capital, LLC6.13%2,755,935
Vik Mittal6.13%2,755,935

Source

View original at SEC

Related